Trial Comparing Treatment Strategies in Triangular Fibrocartilage Complex Ruptures

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Triangular Fibrocartilage Complex Injury

In brief

The trial is a multicentre, randomized, superiority, controlled, participant and outcome assessor (debridement versus placebo surgery randomization cohort) and trialist blinded (both arms) superiority, umbrella trial with two randomized cohorts (1. debridement or placebo surgery, 2. repair or physiotherapy) which both include two 1:1 parallel arms. The primary objective is to investigate the superiority of 1) debridement over placebo surgery and 2) repair over physiotherapy in two randomized cohorts using Patient-Rated Wrist Evaluation (PRWE) at one year post randomisation as the primary outcome.

Key facts

Study ID
NCT04576169
Run by
Tampere University Hospital
People needed
204
Starts
2020-10-27
Expected to finish
2035-03-31
Last updated by the study team
2024-10-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.